Advances in biomarkers and techniques for pancreatic cancer diagnosis

Pancreatic cancer is the most lethal type of malignancy and is characterized by high invasiveness without severe symptoms. It is difficult to detect PC at an early stage because of the low diagnostic accuracy of existing routine methods, such as abdominal ultrasound, CT, MRI, and endoscopic ultrasou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Haotian, Ou, Suwen, Zhang, Hongli, Huang, Rui, Yu, Shan, Zhao, Ming, Tai, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237966/
https://www.ncbi.nlm.nih.gov/pubmed/35761336
http://dx.doi.org/10.1186/s12935-022-02640-9
_version_ 1784736919695917056
author Wu, Haotian
Ou, Suwen
Zhang, Hongli
Huang, Rui
Yu, Shan
Zhao, Ming
Tai, Sheng
author_facet Wu, Haotian
Ou, Suwen
Zhang, Hongli
Huang, Rui
Yu, Shan
Zhao, Ming
Tai, Sheng
author_sort Wu, Haotian
collection PubMed
description Pancreatic cancer is the most lethal type of malignancy and is characterized by high invasiveness without severe symptoms. It is difficult to detect PC at an early stage because of the low diagnostic accuracy of existing routine methods, such as abdominal ultrasound, CT, MRI, and endoscopic ultrasound (EUS). Therefore, it is of value to develop new diagnostic techniques for early detection with high accuracy. In this review, we aim to highlight research progress on novel biomarkers, artificial intelligence, and nanomaterial applications on the diagnostic accuracy of pancreatic cancer.
format Online
Article
Text
id pubmed-9237966
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92379662022-06-29 Advances in biomarkers and techniques for pancreatic cancer diagnosis Wu, Haotian Ou, Suwen Zhang, Hongli Huang, Rui Yu, Shan Zhao, Ming Tai, Sheng Cancer Cell Int Review Pancreatic cancer is the most lethal type of malignancy and is characterized by high invasiveness without severe symptoms. It is difficult to detect PC at an early stage because of the low diagnostic accuracy of existing routine methods, such as abdominal ultrasound, CT, MRI, and endoscopic ultrasound (EUS). Therefore, it is of value to develop new diagnostic techniques for early detection with high accuracy. In this review, we aim to highlight research progress on novel biomarkers, artificial intelligence, and nanomaterial applications on the diagnostic accuracy of pancreatic cancer. BioMed Central 2022-06-28 /pmc/articles/PMC9237966/ /pubmed/35761336 http://dx.doi.org/10.1186/s12935-022-02640-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Wu, Haotian
Ou, Suwen
Zhang, Hongli
Huang, Rui
Yu, Shan
Zhao, Ming
Tai, Sheng
Advances in biomarkers and techniques for pancreatic cancer diagnosis
title Advances in biomarkers and techniques for pancreatic cancer diagnosis
title_full Advances in biomarkers and techniques for pancreatic cancer diagnosis
title_fullStr Advances in biomarkers and techniques for pancreatic cancer diagnosis
title_full_unstemmed Advances in biomarkers and techniques for pancreatic cancer diagnosis
title_short Advances in biomarkers and techniques for pancreatic cancer diagnosis
title_sort advances in biomarkers and techniques for pancreatic cancer diagnosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237966/
https://www.ncbi.nlm.nih.gov/pubmed/35761336
http://dx.doi.org/10.1186/s12935-022-02640-9
work_keys_str_mv AT wuhaotian advancesinbiomarkersandtechniquesforpancreaticcancerdiagnosis
AT ousuwen advancesinbiomarkersandtechniquesforpancreaticcancerdiagnosis
AT zhanghongli advancesinbiomarkersandtechniquesforpancreaticcancerdiagnosis
AT huangrui advancesinbiomarkersandtechniquesforpancreaticcancerdiagnosis
AT yushan advancesinbiomarkersandtechniquesforpancreaticcancerdiagnosis
AT zhaoming advancesinbiomarkersandtechniquesforpancreaticcancerdiagnosis
AT taisheng advancesinbiomarkersandtechniquesforpancreaticcancerdiagnosis

Ejemplares similares